The ability to propagate mature cells and tissue from pluripotent stem cells offers enormous promise for treating many diseases, including neurodegenerative diseases. Before such cells can be used successfully in neurodegenerative diseases without causing unwanted cell growth and migration, genes regulating growth and migration of neural stem cells need to be well characterized. Estrogen receptor beta (ERβ) is essential for migration of neurons and glial cells in the developing mouse brain. To examine whether ERβ influences differentiation of mouse embryonic stem cells (mESC) into neural lineages, we compared control and ERβ knockout (BERKO) mESCs at defined stages of neural development and examined the effects of an ERβ-selective ligand (LY3201) with a combination of global and targeted gene-expression profiling and the expression of key pluripotency markers. We found that ERβ was induced in embryoid bodies (EBs) and neural precursor cells (NPCs) during development. Proliferation was higher in BERKO NPCs and was inhibited by LY3201. Neurogenesis was reduced in BERKO ES cells, and oligodendrogliogenesis was enhanced. BERKO EBs expressed higher levels of key ectodermal and neural progenitor markers and lower levels of markers for mesoderm and endoderm lineages. ERβ-regulated factors are involved in cell adhesion, axon guidance, and signaling of Notch and GABA receptor pathways, as well as factors important for the differentiation of neuronal precursors into dopaminergic neurons (Engrailed 1) and for the oligodendrocyte fate acquisition (Olig2). Our data suggest that ERβ is an important component for differentiation into midbrain neurons as well as for preventing precocious oligodendrogliogenesis. stem cell | estrogen receptor beta | dopamine | oligodendrocyte | midbrain
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stem cell | estrogen receptor beta | dopamine | oligodendrocyte | midbrain D ifferentiation of neural precursor cells (NPCs) into specific neurons and glial cells is the basis for cell-replacement therapy in neurological disorders such as Parkinson's disease (1) (2) (3) . Although successful transplantation of NPCs in animal models of Parkinson's disease has been done (1) (2) (3) , their clinical use is still limited due to challenges such as stem cell tumorigenesis. Therefore, more studies are necessary to understand NPC differentiation, proliferation, and maintenance. One factor that may play an important role here is the ovarian steroid hormone 17β-estradiol (estrogen, E2), which has shown beneficial effects in ameliorating neurodegeneration in animal models (4, 5) and is involved in the survival of midbrain dopaminergic neurons and neurotransmitter synthesis and catabolism (6) .
Estrogenic actions are mediated mainly through two distinct estrogen receptor (ER) subtypes: ERα and ERβ. Both ERs are expressed in the CNS. ERα is the predominant ER in the hypothalamus, arcuate nucleus, and preoptic area, controlling reproduction (7), while ERβ influences nonreproductive processes in the brain. It is the main ER expressed in the cerebral cortex, hippocampus, and the dorsal raphe (8) (9) (10) , where it modulates tryptophan hydroxylase (Tph2) levels (11, 12) . ERβ knockout in mice affects cortical layering and migration of newly formed neurons at later stages of corticogenesis, resulting in hypocellularity in layers II-IV of the somatosensory cortex, which persists in aged mice (13, 14) . However, adult mice lacking ERβ display increased vulnerability to neurodegeneration (15, 16) , increased anxiety-like behavior (17, 18) , perturbed serotonin levels in several brain regions, and lower dopamine levels in the caudate putamen (17) , an area of the midbrain implicated in Parkinson's disease, as well as behavioral deficits related to impaired spatial learning (18, 19) . These changes are not observed in ERα-KO mice (which instead show abnormal behavior linked to reproduction), indicating that ERβ serves as the main ER isoform in regulating neuronal development associated with affective behaviors and cognition. Investigations in mice and rats also indicate that both ERα and ERβ are specifically expressed not only in neurons but also in glial cells in different brain areas during development (20) . ERβ is expressed before the onset of E2 synthesis in the embryonic mouse brain (9) and may affect the cortical layering even though E2 is not present. Also, estradiol-independent activation of ERβ is evidenced by the fact that aromatase-knockout mice (Ar-KO), which are incapable of synthesizing E2, do not show any major aberrations in brain structure (21) . Although it is expressed early in embryonal brain development, a detailed molecular study of the functions of ERβ during neural development remains to be performed.
In the present study, we used mouse ES cells (mESCs) from WT and ERβ-KO (BERKO) mice to delineate the role of ERβ in neural differentiation. We used highly controlled culture conditions
Significance
Controlling the proliferation and proper fate acquisition of pluripotent stem cells is a major challenge in regenerative therapies today. Our study reveals that the estrogen receptor beta (ERβ) is an important factor in maintaining the neuroepithelial and midbrain stem cell pools by repressing proliferation and early nonneuronal fate acquisition. We report on the factors that underlie these effects of ERβ. Further, we report that ERβ facilitates midbrain dopaminergic fate and function. The data presented in this study suggest that ERβ is a factor to be considered in designing regenerative therapies for example neurodegenerative diseases such as Parkinson's disease.
to differentiate mESCs toward defined stages of midbrain neurogenesis, allowing systematic investigation of the effect of loss of ERβ during this process via global and targeted gene-expression profiling. We report that ERβ is necessary for maintaining neural stem cell (NSC) proliferation and self-renewal, likely through Notch-Hes signaling, as well as for decisions of dopaminergicserotonergic neuron specification and function. In addition, the loss of ERβ resulted in the enhanced expression of genes involved in precocious oligodendrogliogenesis.
Results
Pluripotency Characterization of BERKO mESCs and Embryoid Bodies.
Female mESCs from WT and BERKO mice were genotyped to confirm ERβ knockout (SI Appendix, Fig. S1 A, D, and E) and were adapted to feeder-free culture conditions in a chemically defined two-inhibitor medium (2i: MEK and GSK3β inhibitors) in the presence of leukemia inhibitory factor (LIF). The mESCs were then differentiated (Materials and Methods and Fig. 1 ) to four defined stages along the midbrain neuronal lineage commitment: embryoid body (EB), NPC/NSC, midbrain precursor cell (mDPC), and midbrain neuron (MN) (Fig. 1) . The absence of ERβ in BERKO cultures was confirmed by immunocytochemistry (SI Appendix, Fig. S1B ), qPCR (SI Appendix, Fig.  S1C ), and Western blotting (SI Appendix, Fig. S1F ). ERβ was not detectable in ES cells, and there were no measurable differences between WT and BERKO ES cells in pluripotency marker expression (SI Appendix, Fig. S2 ), formation of EBs, or differentiation into the three primary germ layers, ectoderm, mesoderm, and endoderm (SI Appendix, Fig. S3 ).
ERβ was expressed in WT EBs and in all stages of neural development as differentiation progressed. Upon differentiation to the MN stage, ERβ expression was reduced. (SI Appendix, Fig. S1 F and G). A qPCR array containing a panel of genes characteristic of primary germ lineages showed that BERKO EBs expressed higher levels of key ectodermal and neural progenitor markers [Hes family transcription factor 5 (Hes5), mesothelin (Msln), and the transmembrane glycoprotein prominin1 (Prom1)] and lower levels of markers for mesoderm and endoderm lineages (Table 1 and SI Appendix, Fig. S4 ). Thus, ERβ is important in early neural development and has effects as early as the EB cell stage.
BERKO NPCs Exhibit Higher Proliferation. To investigate the mechanisms involved in ERβ regulation of NPCs, we derived a homogeneous population of NPCs from WT and BERKO EBs at differentiation day 10 ( Fig. 1) . Both WT and BERKO NPCs acquired typical neural tube rosette-like morphology and expressed the NSC markers Nestin and Sox2 (SI Appendix, Fig. S5A ). At this stage very few cells were positive for Tubb3, a marker for differentiated neurons (SI Appendix, Fig. S5B ), confirming that both WT and BERKO NPCs constituted a population dominated by NSCs.
We found that proliferation was higher in BERKO NPCs than in WT cells ( Fig. 2A) , with no measurable differences in apoptosis between the genotypes (Fig. 2B) . The ERβ-selective agonist LY3201 (optimal dose set to 0.5 nM) (SI Appendix, Fig. S5C ) (22) lowered WT NPC proliferation by ∼50% but had no effect on BERKO cells (Fig. 2A) . The increased BERKO NPC proliferation was accompanied by decreased expression of the cyclin-dependent kinase (CDK) inhibitors and cell-cycle regulators p27kip1 and p21cip1 in BERKO NPCs, which promote G1-S phase transitions (Fig. 2C) . LY3201 treatment had no effects on the expression of these regulators in both genotypes, suggesting that ERβ functions independently of ligand activation or that the cells synthesize endogenous estradiol. However, the expression of aromatase (Cyp19a1) in EBs and NPCs was very low, at the limit of detection (SI Appendix, Fig. S5D and Dataset S2), which suggests that ERβ may work predominantly independently of ligand activation during early neural differentiation.
Furthermore, we could not observe any compensatory increase in ERα expression in the BERKO NPCs (SI Appendix, Fig. S1C ), and there were no differences in ERα subcellular localization, which was predominantly nuclear, whereas ERβ localization was both nuclear and cytoplasmic (SI Appendix, Fig. S1B ). This strengthens the notion that ERα and ERβ function largely independently and nonredundantly of each other here.
Loss of ERβ Perturbs Notch-Hes Signaling in mESC-Derived NPCs.
NSCs are reliant on Notch-Hes signaling during development, and both Notch and the Hes family of basic helix-loop-helix (bHLH) transcriptional repressors are critical to maintain stemcell identity and avoid depletion through premature differentiation (23) . Hes1, Hes3, and Hes5 are highly expressed in NSCs. Inactivation of Hes genes leads to an increase in proneural genes, acceleration of neurogenesis, and premature depletion of NSCs. In BERKO NPCs the expression of Hes3 transcript was decreased by 75% (Fig. 2C) ; the consequence of this reduction should be a reduction in the proliferation of stem cells, early differentiation, and depletion of the stem-cell pool. In neuroepithelial cells persistent activation of Notch receptors is required for sustained Hes signaling (24) . Notch components (Notch1 receptor and its ligand Dll1) were lower in BERKO NPCs than in WT NPCs (Fig. 2C) . Despite lower Notch signaling and increased proliferation, there was no difference between WT and BERKO NPC cultures in the expression of the neuronal markers Nestin and Tubb3 ( Fig. 2C and SI Appendix, Fig. S5 ). Thus, the increased proliferation appeared to increase a nonneuronal cell pool.
ERβ Is Involved in Midbrain Fate Determination of NSCs. To examine whether ERβ affects MN fate, we induced differentiation of WT and BERKO NPCs toward mDPCs (Fig. 1) . In the BERKO mDPC population there were more midbrain mesencephalic precursors as measured by the expression of ALCAM, indicating precocious differentiation (684.7 ± 26.5) compared with WT mDPCs (441.8 ± 24.8) (Fig. 3A) . At this stage Notch1, Dll1, and Hes3 decreased in the BERKO culture (Fig. 3A) , but there was no change in the number of mature (Tub3 + ) neurons. However, a most interesting change was the reduction of Engrailed genes [75% reduction in Engrailed 1 (En1) and 50% reduction in Engrailed 2 (En2)]. Engrailed genes are key factors for the programming and maintenance of dopaminergic neurons (25) (26) (27) determination revealed a small reduction in orthodenticle homeobox 2 (Otx2), while NK2 homeobox 2 (Nkx2-2) was slightly up-regulated (Fig. 3B ). In line with the changes Otx2 and Nkx2-2 expression, in BERKO mDPCs there was increased expression of markers of serotonergic neurons (Tph2, the rate limiting enzyme for serotonin biosynthesis, and the serotonin transporter, Slc6a4) (Fig. 3B ), but there was no change in the dopaminergic marker tyrosine hydroxylase (Th, a rate-limiting enzyme of dopamine synthesis) or Slc6a3 (a dopamine transporter) (Fig. 3B) . Thus, BERKO mDPCs have a perturbed midbrain neurogenesis and are more prone toward a serotonergic fate (midbrainhindbrain boundary cells) than a dopaminergic fate. Real-time qPCR analysis of transcript levels of the cyclin-dependent kinase inhibitors p21cip1 (p21) and p27kip1 (p27), Notch-Hes pathway components Notch1, Dll1, Hes1, and Hes3, the NSC marker Nestin, and the neural differentiation marker Tubb3 in WT (light green) and BERKO (dark green) NPCs with or without the ERβ ligand LY3201. All transcript levels are normalized to the respective RPLP0 levels in each sample, and log2 changes are shown relative to individual transcript levels in WT NPCs. Values were obtained from three independent experiments with three technical replicates in each and represent the mean ± SEM; **P < 0.01, ***P < 0.001, ****P < 0.0001, two-way ANOVA.
ERβ Maintains Midbrain Neurogenesis and Extracellular Dopamine
Levels. Further differentiation of mDPCs into MNs ( Fig. 1 ) resulted in a cell population composed of a substantial number of dopaminergic as well as serotonergic neurons, with very few neural progenitors (SI Appendix, Fig. S6 ). The percentage of the dopaminergic neurons was significantly lower in BERKO cells (33.9% ± 1.0) than in WT cultures (51.0% ± 1.7) (Fig. 4 A and C). On the other hand, there was an increase in the percentage of serotonergic neurons in BERKO cells (38.4% ± 0.9) as compared with WT cells (21.8% ± 0.8) (Fig. 4 B and C) . Along with this predominance of serotonergic over dopaminergic neurons, there was a marked decrease in Th transcripts (Fig. 4D ) and in the expression of the dopamine transporter Slc6a3 in BERKO cells (Fig. 4D ). In addition, dopamine levels were higher in WT than in BERKO MNs (55.6 ± 12.5 vs. 19.0 ± 7.0 pg/mL) (Fig. 4E) . BERKO MNs expressed higher transcript levels of Tph2 than WT cells (Fig. 4D) , indicative of the shift toward serotonergic neurons. However, there was a marked decrease in the expression of the presynaptic serotonin transporter Slc6a4 in BERKO cells (Fig. 4D) , and there was no significant difference in serotonin release between WT and BERKO-derived MNs (Fig. 4E) , indicating suboptimal serotonergic signaling. In line with this, Tph2
+ BERKO neurons had fewer neurite projections and had a more rounded, spindle-shaped morphology (Fig. 4B) . These findings indicate a selective preference of BERKO midbrain precursors to acquire a serotonergic fate with defective mature functions.
Treatment of mDPCs with LY3201 resulted in higher expression of Th (Fig. 4D ) and dopamine levels (170.8 ± 6.3 pg/mL) compared with untreated (55.6 ± 12.5 pg/mL) or BERKO MNs (19.4 ± 14.4 pg/mL) ( Fig. 4E ) but had no effect on Tph2 or Slc6a4 expression in mature MNs (Fig. 4D) (Fig. 4F ). In addition, the BERKO Alcam + cells had lower expression of the midbrain fate-specific transcription factors Lmx1b and En1 (Fig.  4G ), suggesting that a significant proportion of BERKO mDPCs did not fully differentiate to MNs, resulting in a cell population with a decreased mesencephalic dopaminergic profile.
Gene-Expression Profiling of Neural Developmental Stages. To further explore the molecular underpinnings of the perturbed midbrain neurogenesis in BERKO cells, we performed a global gene-profiling analysis of WT and BERKO cells from different developmental stages and with or without LY3201 treatment. Unsupervised hierarchical clustering of cell types from each developmental stage revealed that mESCs, NPCs, mDPCs, and MNs each have distinct gene-expression patterns that cluster into four distinct classes. Overall, 7,412 genes showed differential gene-expression patterns across all developmental stages, genotypes, and treatments (SI Appendix, Fig. S7 and Datasets S1 and S2). Percentages of differentially expressed genes in the WT and BERKO cell types at each developmental stage are summarized in SI Appendix, Table S1 . Functional enrichment analysis [gene ontology (GO) analysis] of genes differentially regulated in BERKO and WT NPCs and mDPCs revealed pathways related to NSC development and proliferation, such as integrin cellsurface interactions, laminin interactions, extracellular matrix organization, and Wnt and Notch signaling, as well as GABA-A receptor activation, Reelin signaling, and glutamate receptor pathways ( Fig. 5 and SI Appendix, Figs. S8-S11 and Dataset S3). In addition, dopamine metabolic processes were enriched in Values were obtained from three independent experiments with three technical replicates in each and represent means ± SEM; *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001, Student's t test (C, F, and G) or two-way ANOVA (D and E).
mDPCs (SI Appendix, Fig. S10 and Dataset S3). As in NPCs and mDPCs, the pathways affected in the differentiated midbrain stage (MN) were associated with midbrain development and mature neuronal functions, including synaptic transmission and plasticity, axon guidance, and dendrite morphogenesis ( Fig. 5 and SI Appendix, Fig. S11 and Dataset S3). LY3201 had no significant effects on global gene expression at the mESC, NPC, and mDPC stages. However, LY3201 treatment at these precursor stages resulted in effects that were observed only at the MN stage. Some genes strongly affected by early LY3201 treatment were RORc, Tiam2, Dnmt1, Anxa3, and Nuf2 (SI Appendix, Fig. S11D ).
Early Glial Fate Acquisition in ERβ-KO NSCs. Based on the differential gene-expression analysis, the GABA receptors Gabra4, Gabra2, Gabrb1, and Grm3 were highly expressed in BERKO cells (Fig. 6) (28) . Increased expression of Gabra4 in BERKO cultures was confirmed by qPCR analysis and immunocytochemistry ( Fig. 7 A- C, E-G, and I-K). Expression of GABA receptors promotes neurogenesis in the later stages of development, but their early presence participates in the transition of NSCs to oligodendroglial precursors. Furthermore, the microarray data showed that oligodendrocyte-specific factors, such as Omg (oligodendrocyte-myelin glycoprotein) and the oligodendrocyte fate-specific transcription factor Olig2 (oligodendrocyte transcription factor 2) were significantly up-regulated in BERKO cultures (Fig. 6 ). We could confirm the increased expression of Olig2 in all BERKO cultures (Fig. 7 A, C, E, G, I, and K), further suggesting that NSCs lacking ERβ may have difficulties in maintaining proper midbrain differentiation. Along with this preference for the oligodendrocyte over neuronal differentiation pathway, as shown in Fig. 7 , there were more Sox2 + progenitor cells in WT cultures than in BERKO cultures, but in the BERKO cultures a larger percentage of the Sox2 + cells also expressed Olig2 (Fig. 7 D and H) . The percentage of cells that were Olig2
+ was higher in BERKO than in WT MNs (Fig. 7J , Bottom). These data indicate a precocious oligodendroglial fate acquisition in BERKO cultures, which could be due to the reduced Notch signaling at the NPC and mDPC stages.
Some of the genes identified as being strongly down-regulated in BERKO mDPCs and MNs were Roundabout guidance receptor 1 (Robo1), Netrin1 (Ntn1), and the extracellular matrix glycoprotein Reelin (Reln) (Fig. 6 ). Robo1 is involved in axon guidance, while Ntn1 and Reln are important for establishment of cell-cell interactions and neuronal positioning and thus are highly enriched during neurogenesis. We confirmed the downregulation of Reln not only in BERKO mDPCs (Fig. 7 E-G) but also in NPCs (Fig. 7 A-C) and MNs (Fig. 7 I-K) compared with WT cultures. Again, we could not observe any effect when treating the cells with LY3201 or when treating the cells differentiating to MNs with diarylpropionitrile (DPN), a common ERβ-selective agonist (SI Appendix, Fig. S12 ). These results propose that ERβ is a factor in regulating midbrain neurogenesis by modulating cell adhesion, axon guidance, and neurotransmitter processes in a largely ligand-independent manner. In addition, ERβ counteracts precocious oligodendroglial fate acquisition.
Discussion
Directing the differentiation of mESCs to specific cell fates in highly defined culture conditions in vitro is a powerful tool to recapitulate developmental processes and permits understanding of how different factors interact with these processes. Such information is of great value in regenerative therapies for neurological diseases such as Parkinson's disease. Today, regenerative therapies are still in limited use due to the risk of stem cell tumorigenicity and the acquisition of alternate mature fates.
In the present study we used mESCs derived from WT and BERKO mice to investigate the role of ERβ at specific stages of midbrain neural development in vitro: NPC, mDPC, and the mature MN stages. Both ERα and ERβ are highly expressed in the mouse and human developing brain (29) (30) (31) . ERβ expression, which can be measured as early as at E10.5, precedes ERα expression, which is seen only after E16.5 (31) , and the first availability of embryonic estrogen at E18.5 (9) . In the present study, ERα mRNA levels were ∼20-fold lower than ERβ levels in NPCs (SI Appendix, Fig. S1C ). The NPC stage in our study represents E8.5-E9.5.
Analysis of differentiation along the three germ lineages (ectoderm, endoderm, and mesoderm) in WT and BERKO EBs revealed the up-regulation of genes related to neuroectoderm progenitors in BERKO EBs (Table 1) , suggesting either that the neural progenitors in those differentiated EBs did not terminally differentiate or that they were expanding more rapidly. Homogeneously derived BERKO NPCs from BERKO EBs as well as BERKO mDPCs proliferated more than the WT progeny (Figs.  2 and 3A) . Furthermore, the CDK inhibitors p21cip1 (p21) and p27kip1 (p27) were down-regulated. Several studies have shown that ERβ can mediate antiproliferative effects through its direct or indirect repression of cyclin expression and activation of p21 in human breast cancer cells (32) (33) (34) (35) . In addition, the ERβ-selective agonist LY3201 decreased the proliferation of WT NPCs ( Fig. 2A) . NPCs were grown in a medium containing FGF2, a mitogen involved in the growth and proliferation of NSCs; thus the antiproliferative actions of ERβ could be in conjunction with FGF and other growth factor signaling pathways and might be important in preventing the tumorigenicity of stem cells.
A major signaling pathway involved in early embryogenesis is the Notch-Hes pathway. It mediates cell-cell communication, maintains stem cell renewal, and controls neural fate decisions and cell proliferation (23) . Activation of Notch by its ligands (e.g., Delta1/4) induces the expression of transcriptional repressor genes such as Hes1 and Hes5 (canonical) and Hes3 (noncanonical) that repress the expression of proneural genes, culminating in the inhibition of neuronal differentiation. Thus, Notch signaling maintains the NSC population, whereas inactivation or downregulation of Notch signaling results in NSC depletion and induces differentiation to neuronal and oligodendroglial fates (23, (36) (37) (38) (39) . In this study, Notch1, Dll1, Hes1, and Hes3 were all significantly lower in BERKO NPCs and mDPCs than in WT cells.
Depending on the expression dynamics, each Hes factor can have two contradictory functions, promoting either proliferation or cell-cycle exit for differentiation. The oscillatory expression of multiple Hes factors correlates with a proliferative state, whereas fate determination can be attributed to the sustained expression of a selected single Hes factor (40) . Our study reveals that high expression of Hes is not sustained in BERKO progenitor cells, suggesting that ERβ participates in maintaining Notchdependent NSC expansion and self-renewal. Thus, loss of ERβ may promote both proliferation and early imbalances in neural fate acquisitions, which may correlate with oscillatory effects of individual Hes protein expressions. In addition, our gene-profiling analysis points out that integrin signaling pathways are deregulated in BERKO cells throughout neural differentiation, and since Notch signaling cooperates with integrin and growth factor (e.g., FGF) signaling in recognizing the NSC niche (41) , this may impact the neural fate acquisitions.
Our study revealed that the BERKO NPCs and mDPCs had highly increased expression of Olig2, a transcription factor involved in determining oligodendroglial differentiation, which suggests that BERKO NPCs favor oligodendroglial fate acquisition. Furthermore, Nkx2-2, which is coexpressed with Olig2 to promote oligodendrogenesis (42) , was increased in BERKO mDPCs. We also observed the overexpression of GABA-A receptor subunits α2 and α4 (Gabra2 and Gabra4) in BERKO NPCs, mDPCs, and MNs. Oligodendrocyte precursor cells (OPCs) as well as mature oligodendrocytes express GABA-A receptors to receive synaptic input from neurons, which in turn is important for oligodendrocyte survival through increasing intracellular Ca 2+ levels (28) . However, excessive GABA-A receptor activation may cause swelling and damage in the myelinating processes (43) , thereby increasing vulnerability to neurodegeneration. Mice lacking ERβ in oligodendrocytes are more prone to myelin damage than WT mice in the experimental autoimmune encephalitis model of multiple sclerosis (16) . The increased expression of Olig2, Gabra4, and Gabra2, as well as of the oligodendrocytemyelin glycoprotein Omg, in BERKO cultures strongly suggests that the lack of ERβ favors precocious commitment toward an oligodendroglial fate, which in turn could be due to perturbed Notch-Hes signaling in the NPCs. Although no gross phenotypic effects on myelination have been observed in mice lacking ERβ, these data warrant deeper studies on the role of ERβ in myelination and oligodendrocyte function.
In the present study we observed significantly lower levels of both Th and Slc6a3 and lower levels of dopamine in BERKO MN cultures (Fig. 4) . Analysis of factors involved in midbrain development showed a marked down-regulation of the transcription factors En1 and En2 in BERKO mDPCs. En1 and En2, among others, are involved in the determination and patterning of the midbrain/hindbrain precursors and play essential roles in the development and maintenance of mesencephalic dopaminergic neurons (25) (26) (27) . Otx2, which was slightly down-regulated in BERKO mDPCs, is involved in the earlier positioning of the midbrain-hindbrain junction and is also required for the genesis of midbrain precursors. Increased Otx2 expression represses Nkx2-2, a negative regulator of the midbrain dopaminergic program, resulting in a shift to serotonergic neuron differentiation at the expense of dopaminergic neurons. It was reported that ERα and ERβ might mediate ligand-dependent En1 transcription through their interaction with β-catenin and GSK3 of the Wnt signaling pathway (44) . Our results suggest that ERβ may be a key factor in mesencephalic dopaminergic neuron development through its regulation of En1 and En2. LY3201 treatment in our study significantly increased dopamine levels in WT MNs. Thus, although we could not detect any significant transcriptional changes upon LY3201 treatment at the NPC or mDPC stages, ligand activation of ERβ during these early stages nevertheless appears to be important for the mature dopaminergic neuron function in the MN culture, which also expressed the lowest levels of ERβ protein (SI Appendix, Fig. S1 F and G) . Early LY3201 treatment did result in the differential expression of a few genes in the mature MNs, including Rorc, Dnmt1, and Anxa3; Rorc expression was recently shown to be ERβ ligand-mediated in the prostate (55) . These data further suggest that the small changes in gene expression induced by ligand activation of ERβ during early neural development may have significant implications at later or mature stages.
As mentioned above, our study shows that loss of ERβ downregulates the expression of p21, p27, and Notch signaling components in NPCs and mDPCs (Figs. 2 and 3 ) and that LY3201 treatment had no effect on the expression of these genes. It has been shown that ERβ can mediate the expression of p21, p27, and Notch1 in a ligand-independent manner (33) (34) (35) 45) . However, some of these studies also show that the addition of E2 can potentiate this expression. Although the context of ERβ's ligand-independent activation is far from clear, it could be speculated that ERβ's known association with specific transcription factors, such as AP-1 (46, 47) and Steroid receptor coactivator 1 (SRC-1) (48), as well as cell typespecific effects, may be of importance here. In addition, although the neural cells were cultured without serum supplement, the culture medium did contain phenol red, which has weak phytoestrogenic properties, and the possibility that these properties had some agonistic effect on ERβ cannot be ruled out. Unfortunately, the use of phenol red-free medium was not well tolerated by the NPCs during derivation from EBs. These observations warrant further studies of the effects of different estrogenic ligands, including those of antiestrogens and endocrine-disruptive compounds, in different cellular contexts and stages of neural development.
We also observed an increased number of serotonergic neurons in BERKO MNs. Although there was no change in serotonin levels between WT and BERKO MNs, there were more Tph2 + cells in general with abnormal spindle-shaped morphology and short neurite projections in BERKO MNs (Fig. 4 B-E) . We have previously identified a significant reduction in normallooking Tph2
+ cells and an increase in Tph2 + spindle-shaped cells in the dorsal raphe of aged ERβ-KO mice (49) . Similar observations in the present study imply that ERβ, in addition to maintaining serotonergic neurons in the adult brain, may be important at an early stage in the development of these neurons.
Our attention was also drawn to two genes involved in neuronal migration and axon guidance, Reln and Robo1, respectively. Both were down-regulated in BERKO mDPCs and have been proposed to have roles in neurodevelopmental disorders such as dyslexia (50) and schizophrenia (51, 52) . Sexspecific differences in the prevalence of these disorders have been established, and sex hormone receptors such as ERβ may be involved here (reviewed in ref. 53) .
To conclude, the present study demonstrates that the loss of ERβ perturbs the proliferation of neuroepithelial and midbrainstem cells, resulting in increased oligodendrogliogenesis. These effects are likely propagated through Notch-Hes signaling, which is deregulated by the loss of ERβ. Our data also show that ERβ can participate in corticogenesis by regulating genes involved in cell adhesion and axon guidance and that ERβ is needed for proper midbrain fate development through balancing the serotonergic and dopaminergic identity. The maintenance of the latter appears to be mediated through ligand-activated ERβ. These observations are of importance when designing regenerative therapies using NSCs in the treatment of neurodegenerative disorders such as Parkinson's disease, where the development, survival, and functionality of dopaminergic neurons are essential. Fig. S1A . In brief, mESCs were cultured on dishes with irradiated mouse embryonic fibroblasts (KCTT) that had been grown for at least 1 d in ES cell medium containing 1,000 U/mL of LIF (Millipore Inc. or PolyGene AG) in a humidified incubator at 37°C and 5% CO 2 . (See SI Appendix for details.) All animal experiments were carried out according to Swedish guidelines governing animal experimentation, and were approved by the Stockholm South ethics committee of the Karolinska Institutet.
Materials and Methods
EB Formation. EBs were generated at a normally scheduled passage by plating mESCs into non-tissue culture-treated dishes in EB medium without LIF to prevent attachment. EBs were used to test the capability of mESCs to differentiate into three germ layers. After 4 d EBs were plated on a gelatin-coated 100-mm tissue-culture dish in EB medium and were grown/differentiated for 14 d. (See SI Appendix for details.)
Selection and Expansion of NPCs from mESC-Derived EBs. Derivation and selection of NPCs from mESCs and further differentiation to midbrain cells was accomplished using an EB-based method, with modifications of a previously reported protocol (54) . In brief, 4-d-old EBs were plated on gelatin-coated dishes in EB medium supplemented with 15% ES cell-qualified FBS. The medium was replaced by insulin-transferrin-selenium (ITS)-fibronectin (FN) medium, and the EBs were cultured for 6-8 d at 37°C and 5% CO 2 . During this period, a monolayer of cells with rosette-like morphology (NPCs) grew from the attached EBs. After derivation of NPCs, LY3201 (0.5 nM; the kind gift of the Eli Lilly Company) or vehicle (ethanol) treatment was given daily for 4 d after the day of plating. (See SI Appendix for details.)
Differentiation of NPCs to MNs. Midbrain-specific dopaminergic and serotonergic neurons were differentiated from NPCs by midbrain fate specification. In brief, midbrain fate was induced in neural expansion medium supplemented with FGFb (10 ng/mL) (PeproTech), FGF8b (100 ng/mL) (Miltenyi Biotech), sonic hedgehog (Shh) (400 ng/mL) (PeproTech), and ascorbic acid (200 μm) (Tocris). During this period NPCs acquire midbrain fate and generate mDPCs. After derivation of mDPCs, LY3201 (0.5 nM) or vehicle (ethanol) treatment was given daily for 4 d beginning on the day after the day of plating. mDPC differentiation to MNs was induced by culturing the cells for the next 10-15 d in neural expansion medium without growth factors but with ascorbic acid. (See SI Appendix for details.)
Immunocytochemistry and Fluorescence Imaging. Cells were grown on either gelatin-coated (for mESC and EBs) or poly-L-ornithine (100 μg/mL) and Laminin (5 μg/mL, for NPCs) -coated coverslips (Nuvitro) or chambered glass slides (ibidi GmbH) and were fixed in cold 4% paraformaldehyde (Santa Cruz) for 15-20 min followed by three washes in Dulbecco's phosphatebuffered saline, permeabilized, and blocked with 1% BSA (Sigma-Aldrich), 5% normal goat serum (Abcam) or donkey serum (Abcam), and 0.3% Triton X-100 solution in PBS, and stained with the designated primary antibodies (see below) followed by detection with Alexa Fluor secondary antibodies (Invitrogen) and DAPI (300 nM) (Molecular Probes). (See SI Appendix for details.)
Measurement of Dopamine and Serotonin Release. At the final stage of differentiation of NPCs to midbrain cells, culture supernatant was collected for ELISA-based quantification of the key neurotransmitters dopamine and serotonin. Cells were rinsed twice with HBSS and then were incubated with HBSS containing 56 mM KCl for 15 min and were collected to measure evoked neurotransmitter release. Samples were stabilized by adding EDTA (final concentration 1 mM) and sodium metabisulfite (final concentration 4 mM) to prevent catecholamine degradation. The competitive dopamine and serotonin ELISA kits (Abnova) in microtiter plate format were used according to the manufacturer's recommendations using cis-diol-specific affinity gel dopamine/serotonin extraction followed by acylation and enzymatic derivation. The reaction was monitored at 450 nm, and quantification of samples was achieved by comparing their absorbance with a reference curve prepared with known standard concentrations.
Microarray Data Processing and Analysis. Total RNA from NPCs, mDPCs, and MNs treated with vehicle or 0.5 nM LY3201 (according to the scheme in Fig. 1 ) was extracted using the Qiagen Allprep kit following the manufacturer's protocol (Qiagen). The mouse MTA-1.0 microarray (Affymetrix) was used for gene-profiling experiments according to details given in SI Appendix. The data are accessible through Gene Expression Omnibus (GEO) series accession number GSE103312 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi? acc=GSE103312).
Statistical Analysis. Unless stated otherwise, statistical significance was determined using an unpaired, two-tailed Student's t test, assuming unequal variances for single comparisons or using one-way or two-way ANOVA followed by the Tukey post hoc test for multiple comparisons. P values were obtained relative to WT cells if not indicated otherwise. Differences were considered significant if the P value was *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001 for all tests.
